IRIS
GERETTI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.956
AS - Asia 2.946
SA - Sud America 659
EU - Europa 435
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.874
SG - Singapore 1.528
HK - Hong Kong 792
BR - Brasile 560
CN - Cina 255
VN - Vietnam 211
IT - Italia 70
DE - Germania 56
MX - Messico 51
SE - Svezia 48
AR - Argentina 42
GB - Regno Unito 40
IN - India 36
RU - Federazione Russa 32
UA - Ucraina 32
FI - Finlandia 31
FR - Francia 31
AT - Austria 24
ID - Indonesia 23
IE - Irlanda 22
ZA - Sudafrica 21
CA - Canada 20
IR - Iran 16
NL - Olanda 16
PL - Polonia 16
CO - Colombia 15
BD - Bangladesh 13
EC - Ecuador 13
JP - Giappone 13
PY - Paraguay 11
ES - Italia 9
TN - Tunisia 9
AZ - Azerbaigian 8
PK - Pakistan 8
CL - Cile 7
IQ - Iraq 7
EG - Egitto 6
TR - Turchia 6
KR - Corea 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
NP - Nepal 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
DZ - Algeria 2
MW - Malawi 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
NE - Niger 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 7.054
Salva come PNG Salva come JPEG
Città #
Hong Kong 779
Woodbridge 565
Houston 500
Wilmington 472
Singapore 353
Los Angeles 131
Beijing 127
Ashburn 100
Redondo Beach 99
Buffalo 91
Dallas 86
Ho Chi Minh City 78
Fairfield 76
Ann Arbor 56
Chicago 48
The Dalles 45
Hanoi 39
Mexico City 37
Seattle 34
São Paulo 31
Cambridge 30
Jacksonville 24
Dublin 20
Salt Lake City 20
Council Bluffs 18
Rome 17
Lappeenranta 16
New York 16
Tehran 15
Medford 14
Santa Clara 14
Chandler 13
Haiphong 13
Kraków 13
Nuremberg 13
Rio de Janeiro 13
Elk Grove Village 12
Phoenix 12
Shaoxing 12
Dearborn 11
Johannesburg 11
London 11
Tokyo 11
Belo Horizonte 10
Brasília 10
Atlanta 9
Sterling 9
Vienna 9
Baku 8
Changsha 8
Guarulhos 8
Hefei 8
Quito 8
Ribeirão Preto 8
Salvador 8
Stockholm 8
Tampa 8
Dulles 7
Helsinki 7
Lawrence 7
Menlo Park 7
Munich 7
Zhengzhou 7
Biên Hòa 6
Curitiba 6
Denver 6
Orem 6
São Luís 6
Amsterdam 5
Bauru 5
Bogotá 5
Bologna 5
Campinas 5
Chennai 5
Da Nang 5
Duque de Caxias 5
Düsseldorf 5
Fortaleza 5
Jakarta 5
Lima 5
Milan 5
Montreal 5
Ninh Bình 5
Recife 5
Volta Redonda 5
Ankara 4
Asunción 4
Baghdad 4
Boston 4
Brooklyn 4
Buenos Aires 4
Cardiff 4
Chaozhou 4
Charlotte 4
Contagem 4
Dhaka 4
Hyderabad 4
Lancaster 4
Macaé 4
Mauá 4
Totale 4.432
Salva come PNG Salva come JPEG
Nome #
When and how to use maraviroc in HIV-infected patients 430
European guidelines on the clinical management of HIV-1 tropism testing 415
Emerging patterns and implications of HIV-1 integrase inhibitor resistance 379
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: A multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing 376
Optimal use of maraviroc in clinical practice 364
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants 247
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis 214
Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution 174
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy 165
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 60
A contaminant-free assessment of Endogenous Retroviral RNA in human plasma 59
Plasma HIV-1 RNA detection below 50 copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy 58
Research news in clinical context 57
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 55
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 54
A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action 50
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 47
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia 46
Epidemiology of hepatitis B, C and D in Malawi: Systematic review 11 Medical and Health Sciences 1117 Public Health and Health Services 11 Medical and Health Sciences 1108 Medical Microbiology 11 Medical and Health Sciences 1103 Clinical Sciences 43
Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: A cross-sectional comparison with the general population 43
2024 European guidelines for the management of genital herpes 42
Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa 41
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance 35
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses 34
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015 33
Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom 33
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission 32
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIVPositive adults receiving first-line antiretroviral therapy in Malawi 32
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 32
2014 European guideline on HIV testing 31
Primary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation 31
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 31
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 31
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-na{\"i}ve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): Study protocol for a randomised trial 31
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: {'}The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa{'} by Lemoine et al 30
An apparent paradox: Resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy 29
Safety and pharmacokinetic characterization of nacubactam, a novel ?-lactamase inhibitor, alone and in combination with meropenem, in healthy volunteers 29
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 29
HIV-1 subtypes: Epidemiology and significance for HIV management 29
Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: Results from the cross-sectional ASTRA study 28
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions 28
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study). 28
HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination 28
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 28
Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa 27
Antiretroviral resistance 27
The impact of HIV drug resistance testing on changes to treatment 27
Age, time living with diagnosed HIV infection, and self-rated health 27
Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy 27
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients 26
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 26
Attitudes of people in the UK with HIV who are antiretroviral (ART) na{\"i}ve to starting art at high CD4 counts for potential health benefit or to prevent HIV transmission 26
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection 26
During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ 26
Prospective pilot study on the relationship between seminal HIV-1 shedding and genital schistosomiasis in men receiving antiretroviral therapy along Lake Malawi 25
2017 European guidelines for the management of genital herpes 25
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia 25
Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens 25
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors 25
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz 25
Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana 25
Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection 25
Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi 25
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses 25
A virological perspective on resistance in highly treatment-experienced patients 24
Responses to switching to maraviroc-based antiretroviral therapy in treated patients with suppressed plasma HIV-1-RNA load 24
Chasing the infecting HIV-1 24
Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database 24
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study 24
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight) 24
Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection 24
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment 24
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data 24
Reply to Boyd and Lacombe 24
Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom 24
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: A systematic review and pooled analysis 24
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal 24
CROI 2025 BHIVA working group summary 24
Low-level viraemia on HAART: Significance and management 23
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 23
HIV phylogenetics 23
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy 23
Cytotoxic T lymphocytes in AIDS pathogenesis: Lessons to be learned from the macaque model of simian immunodeficiency virus infection 23
National survey of diagnostic services for genital herpes 23
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults 23
Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes 23
BASHH/EAGA position statement on the HIV window period 23
Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy 23
Antiretroviral resistance in clinical practice 22
Point-of-Care Screening for a Current Hepatitis C Virus Infection: Influence on Uptake of a Concomitant Offer of HIV Screening 22
Undiagnosed HIV infection in patients with viral hepatitis 22
HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults 22
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance 21
Kinetics and Specificities of the T Helper?Cell Response to GP120 in the Asymptomatic Stage of HIV-1 Infection 21
Panel discussion 21
HIV: New drugs, new guidelines 21
Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment 21
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression 21
HIV gp120 in the lungs of antiretroviral therapy-treated individuals impairs alveolar macrophage responses to pneumococci 21
Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: A case-control study 21
Totale 5.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 31 40 30 7 11 13 7
2021/202286 3 6 17 2 1 8 3 7 15 4 4 16
2022/202357 8 0 0 6 4 20 6 2 5 0 6 0
2023/202419 3 0 0 0 0 2 0 0 0 10 0 4
2024/20253.043 6 36 28 10 3 59 67 716 886 271 575 386
2025/20262.773 503 473 864 441 413 79 0 0 0 0 0 0
Totale 7.872